VASC 30.33 Vascular Solutions $VASC Hit a 52 week high of 30.50 Closing the day 11/05/14 at 30.33 +0.32 +1.07% With a day low of 29.92 and a total volume of 125,067.
VASC Recent Posts: http://investorshangout.com/Vascular-Solutions-VASC-55784/
VASC Vascular Solutions Recent Headline News
Vascular Solutions to Present at the 2014 Stifel Nicolaus Healthcare Conference
GlobeNewswire - Tue Nov 04, 3:05PM CST
Vascular Solutions, Inc. (Nasdaq:VASC) today announced that the Company is scheduled to present at the 2014 Stifel Nicolaus Healthcare Conference in New York City on Tuesday, November 18th at 4:45pm (EST).
VASC: 30.33 (+0.32)
Vascular Solutions to Distribute PolarCath(TM) Peripheral Dilatation System
GlobeNewswire - Tue Nov 04, 8:00AM CST
Vascular Solutions, Inc. (Nasdaq:VASC) today announced that it has entered into an agreement with NuCryo Vascular LLC under which Vascular Solutions will serve as exclusive distributor of the PolarCath Peripheral Dilatation System in the United States.
VASC: 30.33 (+0.32)
Vascular Solutions Shares Up 36.6% Since SmarTrend's Buy Recommendation (VASC)
Comtex SmarTrend(R) - Thu Oct 30, 4:39PM CDT
SmarTrend identified an Uptrend for Vascular Solutions (NASDAQ:VASC) on June 6th, 2014 at $21.35. In approximately 5 months, Vascular Solutions has returned 36.61% as of today's recent price of $29.16.
VASC: 30.33 (+0.32)
Strong And Under The Radar Today: Vascular Solutions (VASC)
at The Street - Thu Oct 30, 9:11AM CDT
Trade-Ideas LLC identified Vascular Solutions (VASC) as a strong and under the radar candidate
VASC: 30.33 (+0.32)
Vascular Solutions Up 28.6% Since SmarTrend Uptrend Call (VASC)
Comtex SmarTrend(R) - Thu Oct 23, 11:01AM CDT
SmarTrend identified an Uptrend for Vascular Solutions (NASDAQ:VASC) on June 6th, 2014 at $21.35. In approximately 5 months, Vascular Solutions has returned 28.62% as of today's recent price of $27.46.
VASC: 30.33 (+0.32)
Vascular Solutions posts 3Q profit
Automated Insights - Tue Oct 21, 4:31PM CDT
MINNEAPOLIS (AP) _ Vascular Solutions Inc. (VASC) on Tuesday reported profit of $2.6 million in its third quarter.
VASC: 30.33 (+0.32)
Vascular Solutions Reports Third Quarter Results
GlobeNewswire - Tue Oct 21, 3:39PM CDT
- Record quarterly revenues increase 14% to $31.9 million, exceeding the top end of guidance
VASC: 30.33 (+0.32)
Vascular Solutions Shares Up 21.1% Since SmarTrend's Buy Recommendation (VASC)
Comtex SmarTrend(R) - Thu Oct 16, 9:50AM CDT
SmarTrend identified an Uptrend for Vascular Solutions (NASDAQ:VASC) on June 6th, 2014 at $21.35. In approximately 4 months, Vascular Solutions has returned 21.11% as of today's recent price of $25.85.
VASC: 30.33 (+0.32)
Vascular Solutions Has Returned 22.7% Since SmarTrend Recommendation (VASC)
Comtex SmarTrend(R) - Thu Oct 09, 9:14AM CDT
SmarTrend identified an Uptrend for Vascular Solutions (NASDAQ:VASC) on June 6th, 2014 at $21.35. In approximately 4 months, Vascular Solutions has returned 22.75% as of today's recent price of $26.20.
VASC: 30.33 (+0.32)
Vascular Solutions, Inc. to Webcast Third Quarter Conference Call
GlobeNewswire - Thu Oct 02, 3:05PM CDT
Vascular Solutions, Inc. (Nasdaq:VASC) today announced that it will host a live webcast of its third quarter conference call on Tuesday, October 21 at 3:30pm CST. Vascular Solutions' Chief Executive Officer, Howard Root, Chief Financial Officer, James Hennen and VP of Corporate Development, Phil Nalbone, will discuss the company's third quarter results. The company will issue an earnings news release after market close on Tuesday, October 21.
VASC: 30.33 (+0.32)
U.S. Market for Wound and Tissue Management 2014
M2 - Wed Oct 01, 6:48AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9xtlbb/u_s_market_for) has announced the addition of the "U.S. Market for Wound and Tissue Management 2014" report to their offering. The U.S market for wound and tissue management was driven by the introduction of newly FDA-approved products, and by demand due to the aging population, and increasing rates of both obesity and diabetes. The advanced wound dressings segment exhibited the highest growth in 2013. This growth will be due to the rising popularity of foam dressings, antimicrobial dressings and the influx of competitors and innovative products in the interactive dressing market. The reimbursement changes in 2014 will potentially have a negative impact on the growth of the interactive dressing market. Growth in the negative pressure wound therapy market was significantly affected by the competitive bidding process. This market is expected to rebound and post growth in the high single-digits over the forecast period. Growth will be supplemented by improved reimbursement rates for single use negative pressure wound therapy pumps and an increase in the number of competitors. Report Highlights: - Introduction of newly FDA-approved products - Reimbursement change effects on the market - Mainstay products in the wound closure market, such as sutures - Improved advanced wound closure devices, such as cyanoacrylate-based tissue adhesives - DME competitive bidding proccess effects on various markets Key Topics Covered: 1. Executive Summary 2. Research Methodology 3. U.S. Wound And Tissue Management Market Overview 4. Wound Closure Market 5. Static Compression Therapy Market 6. Dynamic Compression Therapy Market 7. Advanced Dressing Market Overview 8. Moist Dressing Market 9. Antimicrobial Dressing Market 10. Interactive Dressing Market 11. Non-Adherent Contact Layer Market 12. Traditional Wound Dressing Market 13. Hemostat Market 14. Tissue Sealant Market 15. Anti-Adhesion Market 16. Negative Pressure Wound Therapy Market Companies Mentioned - 3M - ArjoHuntleigh - BSN-JOBST - Baxter - Bayer - Bio Compression Systems - C. R. Bard - Carolon - Celox - Circulator Boot Corporation - ConvaTec - Covidien - Ethicon - Genzyme - HARTMANN-CONCO - HemCon - Integra Lifesciences - Lympha Press - MCS - Medicines Company - mediUSA - Medline - Organogenesis - Osiris - Pfizer - SIGVARIS - Smith & Nephew - Stryker (Orthovita) - Vascular Solutions - Z-Medica For more information visit http://www.researchandmarkets.com/research/9x...market_for
SNN: 34.22 (+0.45), MDCO: 23.99 (-1.60), VASC: 30.33 (+0.32)
12.0% Return Seen to Date on SmarTrend Vascular Solutions Call (VASC)
Comtex SmarTrend(R) - Wed Sep 24, 11:19AM CDT
SmarTrend identified an Uptrend for Vascular Solutions (NASDAQ:VASC) on June 6th, 2014 at $21.35. In approximately 4 months, Vascular Solutions has returned 12.02% as of today's recent price of $23.91.
VASC: 30.33 (+0.32)
Uptrend Call Working As Vascular Solutions Stock Rises 10.2% (VASC)
Comtex SmarTrend(R) - Tue Sep 09, 9:23AM CDT
SmarTrend identified an Uptrend for Vascular Solutions (NASDAQ:VASC) on June 6th, 2014 at $21.35. In approximately 3 months, Vascular Solutions has returned 10.19% as of today's recent price of $23.52.
VASC: 30.33 (+0.32)
Vascular Solutions Up 14.3% Since SmarTrend Uptrend Call (VASC)
Comtex SmarTrend(R) - Fri Aug 22, 9:45AM CDT
SmarTrend identified an Uptrend for Vascular Solutions (NASDAQ:VASC) on June 6th, 2014 at $21.35. In approximately 3 months, Vascular Solutions has returned 14.31% as of today's recent price of $24.40.
VASC: 30.33 (+0.32)
Vascular Solutions Has Returned 15.2% Since SmarTrend Recommendation (VASC)
Comtex SmarTrend(R) - Thu Aug 14, 5:02PM CDT
SmarTrend identified an Uptrend for Vascular Solutions (NASDAQ:VASC) on June 6th, 2014 at $21.35. In approximately 2 months, Vascular Solutions has returned 15.20% as of today's recent price of $24.59.
VASC: 30.33 (+0.32)
Shares of VASC Up 15.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Jul 31, 10:02AM CDT
SmarTrend identified an Uptrend for Vascular Solutions (NASDAQ:VASC) on June 6th, 2014 at $21.35. In approximately 2 months, Vascular Solutions has returned 15.86% as of today's recent price of $24.73.
VASC: 30.33 (+0.32)
VASC Recent Posts: http://investorshangout.com/Vascular-Solutions-VASC-55784/
VASC Vascular Solutions Recent Headline News
Vascular Solutions to Present at the 2014 Stifel Nicolaus Healthcare Conference
GlobeNewswire - Tue Nov 04, 3:05PM CST
Vascular Solutions, Inc. (Nasdaq:VASC) today announced that the Company is scheduled to present at the 2014 Stifel Nicolaus Healthcare Conference in New York City on Tuesday, November 18th at 4:45pm (EST).
VASC: 30.33 (+0.32)
Vascular Solutions to Distribute PolarCath(TM) Peripheral Dilatation System
GlobeNewswire - Tue Nov 04, 8:00AM CST
Vascular Solutions, Inc. (Nasdaq:VASC) today announced that it has entered into an agreement with NuCryo Vascular LLC under which Vascular Solutions will serve as exclusive distributor of the PolarCath Peripheral Dilatation System in the United States.
VASC: 30.33 (+0.32)
Vascular Solutions Shares Up 36.6% Since SmarTrend's Buy Recommendation (VASC)
Comtex SmarTrend(R) - Thu Oct 30, 4:39PM CDT
SmarTrend identified an Uptrend for Vascular Solutions (NASDAQ:VASC) on June 6th, 2014 at $21.35. In approximately 5 months, Vascular Solutions has returned 36.61% as of today's recent price of $29.16.
VASC: 30.33 (+0.32)
Strong And Under The Radar Today: Vascular Solutions (VASC)
at The Street - Thu Oct 30, 9:11AM CDT
Trade-Ideas LLC identified Vascular Solutions (VASC) as a strong and under the radar candidate
VASC: 30.33 (+0.32)
Vascular Solutions Up 28.6% Since SmarTrend Uptrend Call (VASC)
Comtex SmarTrend(R) - Thu Oct 23, 11:01AM CDT
SmarTrend identified an Uptrend for Vascular Solutions (NASDAQ:VASC) on June 6th, 2014 at $21.35. In approximately 5 months, Vascular Solutions has returned 28.62% as of today's recent price of $27.46.
VASC: 30.33 (+0.32)
Vascular Solutions posts 3Q profit
Automated Insights - Tue Oct 21, 4:31PM CDT
MINNEAPOLIS (AP) _ Vascular Solutions Inc. (VASC) on Tuesday reported profit of $2.6 million in its third quarter.
VASC: 30.33 (+0.32)
Vascular Solutions Reports Third Quarter Results
GlobeNewswire - Tue Oct 21, 3:39PM CDT
- Record quarterly revenues increase 14% to $31.9 million, exceeding the top end of guidance
VASC: 30.33 (+0.32)
Vascular Solutions Shares Up 21.1% Since SmarTrend's Buy Recommendation (VASC)
Comtex SmarTrend(R) - Thu Oct 16, 9:50AM CDT
SmarTrend identified an Uptrend for Vascular Solutions (NASDAQ:VASC) on June 6th, 2014 at $21.35. In approximately 4 months, Vascular Solutions has returned 21.11% as of today's recent price of $25.85.
VASC: 30.33 (+0.32)
Vascular Solutions Has Returned 22.7% Since SmarTrend Recommendation (VASC)
Comtex SmarTrend(R) - Thu Oct 09, 9:14AM CDT
SmarTrend identified an Uptrend for Vascular Solutions (NASDAQ:VASC) on June 6th, 2014 at $21.35. In approximately 4 months, Vascular Solutions has returned 22.75% as of today's recent price of $26.20.
VASC: 30.33 (+0.32)
Vascular Solutions, Inc. to Webcast Third Quarter Conference Call
GlobeNewswire - Thu Oct 02, 3:05PM CDT
Vascular Solutions, Inc. (Nasdaq:VASC) today announced that it will host a live webcast of its third quarter conference call on Tuesday, October 21 at 3:30pm CST. Vascular Solutions' Chief Executive Officer, Howard Root, Chief Financial Officer, James Hennen and VP of Corporate Development, Phil Nalbone, will discuss the company's third quarter results. The company will issue an earnings news release after market close on Tuesday, October 21.
VASC: 30.33 (+0.32)
U.S. Market for Wound and Tissue Management 2014
M2 - Wed Oct 01, 6:48AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9xtlbb/u_s_market_for) has announced the addition of the "U.S. Market for Wound and Tissue Management 2014" report to their offering. The U.S market for wound and tissue management was driven by the introduction of newly FDA-approved products, and by demand due to the aging population, and increasing rates of both obesity and diabetes. The advanced wound dressings segment exhibited the highest growth in 2013. This growth will be due to the rising popularity of foam dressings, antimicrobial dressings and the influx of competitors and innovative products in the interactive dressing market. The reimbursement changes in 2014 will potentially have a negative impact on the growth of the interactive dressing market. Growth in the negative pressure wound therapy market was significantly affected by the competitive bidding process. This market is expected to rebound and post growth in the high single-digits over the forecast period. Growth will be supplemented by improved reimbursement rates for single use negative pressure wound therapy pumps and an increase in the number of competitors. Report Highlights: - Introduction of newly FDA-approved products - Reimbursement change effects on the market - Mainstay products in the wound closure market, such as sutures - Improved advanced wound closure devices, such as cyanoacrylate-based tissue adhesives - DME competitive bidding proccess effects on various markets Key Topics Covered: 1. Executive Summary 2. Research Methodology 3. U.S. Wound And Tissue Management Market Overview 4. Wound Closure Market 5. Static Compression Therapy Market 6. Dynamic Compression Therapy Market 7. Advanced Dressing Market Overview 8. Moist Dressing Market 9. Antimicrobial Dressing Market 10. Interactive Dressing Market 11. Non-Adherent Contact Layer Market 12. Traditional Wound Dressing Market 13. Hemostat Market 14. Tissue Sealant Market 15. Anti-Adhesion Market 16. Negative Pressure Wound Therapy Market Companies Mentioned - 3M - ArjoHuntleigh - BSN-JOBST - Baxter - Bayer - Bio Compression Systems - C. R. Bard - Carolon - Celox - Circulator Boot Corporation - ConvaTec - Covidien - Ethicon - Genzyme - HARTMANN-CONCO - HemCon - Integra Lifesciences - Lympha Press - MCS - Medicines Company - mediUSA - Medline - Organogenesis - Osiris - Pfizer - SIGVARIS - Smith & Nephew - Stryker (Orthovita) - Vascular Solutions - Z-Medica For more information visit http://www.researchandmarkets.com/research/9x...market_for
SNN: 34.22 (+0.45), MDCO: 23.99 (-1.60), VASC: 30.33 (+0.32)
12.0% Return Seen to Date on SmarTrend Vascular Solutions Call (VASC)
Comtex SmarTrend(R) - Wed Sep 24, 11:19AM CDT
SmarTrend identified an Uptrend for Vascular Solutions (NASDAQ:VASC) on June 6th, 2014 at $21.35. In approximately 4 months, Vascular Solutions has returned 12.02% as of today's recent price of $23.91.
VASC: 30.33 (+0.32)
Uptrend Call Working As Vascular Solutions Stock Rises 10.2% (VASC)
Comtex SmarTrend(R) - Tue Sep 09, 9:23AM CDT
SmarTrend identified an Uptrend for Vascular Solutions (NASDAQ:VASC) on June 6th, 2014 at $21.35. In approximately 3 months, Vascular Solutions has returned 10.19% as of today's recent price of $23.52.
VASC: 30.33 (+0.32)
Vascular Solutions Up 14.3% Since SmarTrend Uptrend Call (VASC)
Comtex SmarTrend(R) - Fri Aug 22, 9:45AM CDT
SmarTrend identified an Uptrend for Vascular Solutions (NASDAQ:VASC) on June 6th, 2014 at $21.35. In approximately 3 months, Vascular Solutions has returned 14.31% as of today's recent price of $24.40.
VASC: 30.33 (+0.32)
Vascular Solutions Has Returned 15.2% Since SmarTrend Recommendation (VASC)
Comtex SmarTrend(R) - Thu Aug 14, 5:02PM CDT
SmarTrend identified an Uptrend for Vascular Solutions (NASDAQ:VASC) on June 6th, 2014 at $21.35. In approximately 2 months, Vascular Solutions has returned 15.20% as of today's recent price of $24.59.
VASC: 30.33 (+0.32)
Shares of VASC Up 15.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Jul 31, 10:02AM CDT
SmarTrend identified an Uptrend for Vascular Solutions (NASDAQ:VASC) on June 6th, 2014 at $21.35. In approximately 2 months, Vascular Solutions has returned 15.86% as of today's recent price of $24.73.
VASC: 30.33 (+0.32)
